ProPharma Group Announces the Acquisition of Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition…
Read Blog PostMydecine Innovations Group Engages ProPharma Group to Proceed with FDA...
Leading FDA consultancy firm to advise on drug development and clinical trial…
Read Blog PostOdyssey Investment Partners To Acquire ProPharma Group
Odyssey Investment Partners (“Odyssey”) announced today that it has entered into an…
Read Blog PostLinden Agrees to Sell ProPharma Group to Odyssey Investment Partners
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on…
Read Blog PostProPharma Group Announces Acquisition of Southwood Research
Southwood Research is a leading provider of pre-approval regulatory science services to…
Read Blog PostProPharma Group Acquires The Weinberg Group
ProPharma Group, a leading provider of compliance services, continues to expand its…
Read Blog PostProPharma Group Announces Acquisition of SOLUTIONS in Health
ProPharma Group announces the acquisition of SOLUTIONS in Health Inc., a Canada-based…
Read Blog PostProPharma Group Announces New Medical Information Contact Center
ProPharma Group today announces the opening of a new medical information contact…
Read Blog PostYour Business has Complex Challenges. ProPharma Group has Exceptional Solutions.
We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.
Interested in gaining an industry edge? Let us help you stay up to date.
Sign up to receive updates and industry insights